Twitter LinkedIn
    Friday, June 9
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Fundraising»Sheridan Capital Partners Fund II closes above hard cap at USD306m
    Fundraising

    Sheridan Capital Partners Fund II closes above hard cap at USD306m

    January 21, 20212 Mins Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Sixpoint Partners, a leading global investment bank serving the middle market, has held the closing of Sheridan Capital Partners Fund II, above its hard cap with USD306 million of total capital commitments.

    Sheridan Capital Partners (“Sheridan”) is focused on making investments in lower middle market companies in recession resistant, non-discretionary markets within the healthcare industry. The Fund will continue Sheridan’s strategy of making control investments in North American founder-owned businesses with USD3-15 million of EBITDA. Sheridan is led by Partners Jonathan Lewis and Sean Dempsey.

    “We are extremely pleased with the overwhelming support provided by our investor base, which encompasses a high-quality group of internationally diversified insurance companies, fund-of-funds, family offices and asset managers,” says Jonathan Lewis, Founder & Partner at Sheridan.

    “Sixpoint Partners’ continued strategic advice and support throughout the process were instrumental in the successful outcome of the fundraise,” says Sean Dempsey, Partner at Sheridan.

    “Sheridan’s oversubscribed sophomore fundraise in a highly selective environment shows a strong vote of confidence in Jonathan, Sean and the rest of the Sheridan team,” says Eric Zoller, Founder & Partner at Sixpoint Partners.

    “Sheridan has established itself as a leader in the lower middle market healthcare space and we look forward to a long-term partnership as they continue to generate value for their investors by building differentiated, market-leading platforms within lower middle market healthcare,” says Matt Thornton, Partner at Sixpoint Partners.

    Source: Private Equity wire

     

    Image Source

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Fundraising funds Investments Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Parthenon Capital closes Fund VII at $4.5bn

    April 3, 2023

    Euroclear moves into $9.8 trillion private asset market with Goji buy

    December 21, 2022

    CAI raises over $1B for inaugural fund and co-investment programme

    November 18, 2022

    KKR looking to sell Canadian gas producer Westbrick for $1.13B

    November 18, 2022

    Comments are closed.

    Other Articles

    ByteDance acquires gaming studio Moonton at around $4 billion valuation

    March 23, 2021

    Pay at private equity firms ‘dwarfs’ sums on offer to investment bankers

    February 15, 2022

    ThoughtWorks Receives $720 Million Investment at an Enterprise Value of $4.6 Billion

    January 16, 2021

    GrowthGenius Secures $1.8M in Funding to Scale Sales Prospecting Automation Platform

    August 23, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?